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ABSTRACT
Mycoplasma pneumoniae (MP) is a common cause of respiratory infections and can be associated with extrapulmonary complications. MP 
mucositis has recently been described as a distinct endemic clinical entity called Mycoplasma pneumoniae-induced rash and mucositis 
(MIRM). The authors present the case of a 46-year-old man with atypical pneumonia associated with exuberant mucositis, conjunctival 
hyperaemia and positive serological assays for MP IgM. The patient was treated with azithromycin and systemic corticosteroid therapy. 
Supportive care including pain management, intravenous hydration and mucosal care was also given. There was complete resolution of 
the pneumonia and mucositis. The presence of atypical pneumonia with mucosal involvement without cutaneous lesions and a favourable 
clinical evolution led to the diagnosis of MIRM.
LEARNING POINTS
• Mycoplasma pneumoniae infection can be associated with mucocutaneous lesions. A new entity called Mycoplasma pneumoniae-induced 
rash and mucositis (MIRM) has been recently described. The mucocutaneous involvement associated with MIRM is predominantly 
mucositis with scarce or absent cutaneous expression. 
• The clinical presentation, pathophysiology and disease outcomes of MIRM distinguish it from Stevens-Johnson syndrome/toxic 
epidermal necrolysis and erythema multiform. 
• MIRM has an overall favourable prognosis as the majority of patients recover without sequalae and recurrence is rare.
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CASE DESCRIPTION
A 46-year-old man who worked in forestry was admitted to the emergency department (ED) with a 12-day history of fever, malaise, 
headache, rhinorrhoea, mildly productive cough and odynophagia. He also reported a 2- day history of bilateral conjunctival hyperaemia 
and exuberant mucositis associated with a decrease in food intake due to odynophagia. Ten days before admission the patient had been 
prescribed amoxicillin/clavulanic acid by his general practitioner. On admission to the ED, the patient was haemodynamically stable, 
eupnoeic and febrile (tympanic temperature of 38.5ºC), with exuberant mucositis and bilateral conjunctival hyperaemia without cutaneous 
lesions or lesions in the genital region. Pulmonary auscultation presented bibasilar crackles. 
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2018_000977 European Journal of Case Reports in Internal Medicine © EFIM 2018
METHODS AND PROCEDURES
Blood examinations showed an elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) (CRP 15.32 mg/dl, ESR 65 mm), 
leucocytosis (leucocytes 14,000/µl) with neutrophilia (neutrophils 8,000/µl) and mild cytocholestasis. Chest x-ray revealed a reticulonodular 
infiltrate in both pulmonary bases which corresponds to an atypical pneumonia pattern. The remaining examinations showed negative 
immunological screening, a non-reactive VDRL (Venereal Disease Research Laboratory) test, and negative screening tests for hepatitis B 
and C viruses, human immunodeficiency virus, cytomegalovirus, Epstein-Barr virus, Chlamydophila pneumoniae, Rickettsia conorii, Coxiella 
burnetii, Borrelia burgdorferi, Leptospira and Legionella pneumophila. Serology-based assays were positive for Mycoplasma pneumoniae (MP) 
IgM. The otorhinolaryngological examination revealed extensive mucositis with confluent ulcers on the oropharynx and hypopharynx (grade 
3 mucositis) (Fig. 1). The ophthalmological examination revealed exuberant conjunctival hyperaemia, follicles on the tarsal conjunctiva, 
inflammatory membranes adherent to the conjunctiva and superficial punctate keratitis (Fig. 2). 
Figure 1. Oral mucositis with confluent ulcers on the oropharynx and hypopharynx
Figure 2. Conjunctival hyperaemia
During hospitalisation, the patient was treated with azithromycin 500 mg/day and gentamicin/dexamethasone eye drops (3/1 mg/ml) 
four times per day. Supportive care was given, including intravenous hydration and pain management with systemic analgesics. An oral 
suspension of nystatin and lidocaine was applied for oral mucosa care and artificial tear drops were applied for ocular lubrication. Due to 
the odynophagia, the patient received an individualised diet of semi-liquid food with protein-caloric supplementation. On the 7th day of 
hospitalisation due to persistence of the exuberant mucositis and conjunctivitis, systemic corticosteroid therapy with methylprednisolone 1 
mg/kg/day was initiated. There was a favourable clinical evolution and the patient was discharged on the 13th day with mild mucosal lesions 
and mild conjunctival hyperaemia. One week after discharge the patient showed complete remission of the lesions.
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DISCUSSION
MP is a common cause of respiratory infections. In 25% of cases there are extrapulmonary complications, namely mucocutaneous lesions 
[1–5]. The MP spectrum of dermatological manifestations is varied and includes Raynaud's disease, erythema nodosum, Kawasaki disease, 
erythema multiforme (EM) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)[2–5]. Mucositis with or without scarce 
cutaneous involvement associated with MP infection is rare. Previously this clinical condition was classified within the epidermolytic 
dermopathy spectrum, being classified as ‘atypical SSJ’, ‘incomplete SSJ’ or ‘Fuchs syndrome’ [1,2,4]. A recent systematic review concluded that 
this condition is actually a distinct entity called Mycoplasma pneumoniae-induced rash and mucositis (MIRM)[1]. The MIRM characteristics 
include predominance of mucosa involvement (two or more mucosal sites) and scarce or absent cutaneous involvement (when present it 
manifests as a vesiculobullous or targetoid eruption), appearance at a younger age, a favourable prognosis with rare recurrence and a low 
mortality rate[1–3]. The pathophysiology of MIRM is unclear. It is thought to be caused by the production of immunoglobulins due to the 
proliferation of B cell clones which leads to the deposition of immune complexes in the mucocutaneous tissues. This pathophysiology is 
distinct from the pathophysiology of EM and SJS/TEM, as the latter are both mediated by a type IV delayed hypersensitivity reaction[1–3]. 
In the present case, the presence of a combination of factors enabled the diagnosis of MIRM: exclusive mucosal involvement, clinical and 
radiological findings of an atypical pneumonia and positive MP serology. This case also had a similar clinical course to other cases described 
in the literature in which respiratory symptoms preceded oral and ocular lesions[4, 5].
There are no guidelines for MIRM treatment but most of the cases described in the literature were treated with antibiotics, immunomodulators 
(corticoid and/ or intravenous immunoglobulins) and supportive care[1–5]. Although antibiotic treatment directed at MP eliminates 
the causative agent and limits the duration and severity of the pulmonary disease, it is unclear whether the incidence or severity of the 
mucocutaneous eruption is reduced[1]. Macrolides are the most widely used antibiotics, mainly because of their immunomodulatory effect[5]. 
Although the role of immunomodulatory therapies is not clear, there is clinical evidence of the benefits of these drugs for the treatment of 
severe mucositis in reducing complications associated with mucous membrane adhesions[1].
In the present case, the positive clinical evolution with total resolution of lesions is consistent with the diagnosis of MIRM. Recognition of 
MIRM as an independent entity has raised awareness and facilitated diagnosis and timely initiation of appropriate treatment. 
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